TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+0.75%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.44B
AUM Growth
+$2.44B
(-4%)
Cap. Flow
-$52.5M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
38.65%
Holding
187
New
10
Increased
35
Reduced
38
Closed
19
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$43.6M |
| 2 |
Humana
HUM
|
$23.9M |
| 3 |
Eli Lilly
LLY
|
$20.7M |
| 4 |
Illumina
ILMN
|
$18.9M |
| 5 |
Abbott
ABT
|
$15.8M |
Top Sells
| 1 |
McKesson
MCK
|
$43.2M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$23.3M |
| 3 |
UnitedHealth
UNH
|
$23M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$21.7M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$19.4M |
Sector Composition
| 1 | Healthcare | 96.9% |
| 2 | Real Estate | 1.86% |
| 3 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
iTeos Therapeutics
ITOS
$449M
| – | – | -21,181 | Closed | -$436K |
|
177
Protagonist Therapeutics
PTGX
$3.67B
| – | – | -122,271 | Closed | -$967K |
|
178
Qiagen
QGEN
$10.1B
| – | – | -10,500 | Closed | -$496K |
|
179
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – | -56,480 | Closed | -$1.09M |
|
180
Universal Health Services
UHS
$11.6B
| – | – | -4,000 | Closed | -$403K |
|
|
VRNA
181
Verona Pharma
VRNA
$9.16B
| – | – | -751,905 | Closed | -$3.15M |
|
182
Waters Corp
WAT
$18B
| – | – | -3,600 | Closed | -$1.19M |
|
183
ZimVie
ZIMV
$532M
| – | – | -14,202 | Closed | -$227K |
|
|
SYNH
184
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – | -302,945 | Closed | -$21.7M |
|
|
HR
185
DELISTED
Healthcare Realty Trust Incorporated
HR
| – | – | -104,024 | Closed | -$2.83M |
|